Home » Topics » Regulatory » Patents

Patents
RSS

Novel orexin OX1 receptor antagonists discovered at C4X Discovery Holdings

Aug. 11, 2017

Guangzhou Institutes of Biomedicine and Health presents novel RORC antagonists

Aug. 11, 2017

Sumitomo Dainippon Pharma divulges new semaphorin-3A inhibitors

Aug. 11, 2017

Beijing Marino Biotechnology describes a transgenic lymphocyte construct identifying EGFRvIII

Aug. 11, 2017

Yeda Research & Development patents protein LYRIC/transcription factor p65 interaction inhibitors

Aug. 11, 2017

Shanghai Institute Materia Medica, Sunnylife Pharma disclose BTK inhibitors

Aug. 10, 2017

Merck & Co. patents anti-coagulation factor XI antibodies

Aug. 10, 2017

Servier, Vernalis divulge novel Mcl-1 inhibitors

Aug. 10, 2017

American Gene Technologies International presents farnesyl diphosphate synthase inhibitors

Aug. 10, 2017

Taipei Medical University identifies new niclosamide prodrugs

Aug. 10, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...